StockData
Ocugen, Inc. logo

Ocugen, Inc. (OCGN) stock

OCGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$0.76−0.02 (-2.11%)

Close on Nov 17, 2026Market cap $256.61MP/E –Yield –

Ocugen price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Ocugen's price to book ratio was 71.7× on Jul 31, 2026, against 7.3× a year earlier. Over the last 5 years it ranged from 1.6× to 156.1×, with a median of 7.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 202671.7×−47.7
2025Dec 31, 2025119.3×+113.6
2024Dec 31, 20245.8×+2.8
2023Dec 29, 20233.0×−0.3
2022Dec 30, 20223.3×−5.2
2021Dec 31, 20218.5×−12.1
2020Dec 31, 202020.6×−126.2
2018Apr 30, 2018146.8×+88.0
2017Jul 31, 201758.8×−6.9
2016Dec 30, 201665.7×+52.8
2015Dec 31, 201512.8×–

More Ocugen figures

See a number that looks wrong?